Palantir Shares Surge Over 16% in Pre-Market Trading: Here's Why and 20 Other Stocks Moving Premarket
Generated by AI AgentWesley Park
Tuesday, Feb 4, 2025 5:25 am ET1min read
PLTR--
Palantir Technologies Inc. (PLTR) shares are trading higher by over 16% in the pre-market session, following a strong fourth-quarter earnings report and an upgrade from Wedbush analyst Dan Ives. The company reported fourth-quarter revenue of $827.52 million, beating the consensus estimate of $775.91 million, and adjusted earnings of 14 cents per share, surpassing analyst estimates of 11 cents per share. Ives maintained a buy rating and increased his price target to $75, representing about 13% upside compared to Monday's closing price. He noted that under a Trump Administration, major AI initiatives within the U.S. government, including the Department of Defense, would be a significant tailwind for AI players like Palantir.

Palantir's strong performance can be attributed to several factors, including its accelerating growth, strategic partnerships, and acquisitions. The company's growth has been accelerating for the past five consecutive quarters, with revenue increasing by 30% year over year in the third quarter. Palantir's AI platform, AIP, has been a significant driver of the company's growth, with U.S. commercial revenue increasing by 54% year over year. The company's customer count for its AIP platform rose by 77% year over year, pushing its remaining deal value (RDV) up by 73%. Palantir's strategic partnerships and acquisitions, such as its investment in Shield AI and its partnership with SpaceX, have also contributed to its growth and stock price appreciation.
In addition to Palantir, several other stocks are moving in the pre-market session. Gainers include:
* Evaxion Biotech A/S (EVAX): +72.5% to $4.14
* Kairos Pharma, Ltd. (KAPA): +40.1% to $2.13
* Azitra, Inc. (AZTR): +40% to $0.3900
* Invivyd, Inc. (IVVD): +27.4% to $1.35
* CleanCore Solutions, Inc. (ZONE): +25.5% to $1.28
* Reborn Coffee, Inc. (REBN): +17.8% to $6.00
* American Rebel Holdings, Inc. (AREB): +16% to $1.38
* Tempus AI, Inc. (TEM): +8% to $66.44
* XPeng Inc. (XPEV): +7% to $16.79
Losers include:
* Universe Pharmaceuticals INC (UPC): -28.2% to $0.3012
* MDJM Ltd (UOKA): -27.2% to $0.1730
* E-Home Household Service Holdings Limited (EJH): -25% to $0.7652
* BriaCell Therapeutics Corp. (BCTX): -22.6% to $3.90
* Tonix Pharmaceuticals Holding Corp. (TNXP): -20.2% to $0.1555
* HCW Biologics Inc. (HCWB): -16.1% to $0.5335
* XChange TEC.INC (XHG): -14.2% to $0.7166
* UBS Group AG (UBS): -6.1% to $32.81
* Ponce Financial Group, Inc. (PDLB): -5.3% to $12.61
* Illumina, Inc. (ILMN): -5.2% to $124.31
Palantir's strong performance and the movement of other stocks in the pre-market session highlight the importance of staying informed about earnings reports, analyst upgrades, and strategic developments. By keeping a close eye on these factors, investors can make well-informed decisions and capitalize on opportunities in the market.
Palantir Technologies Inc. (PLTR) shares are trading higher by over 16% in the pre-market session, following a strong fourth-quarter earnings report and an upgrade from Wedbush analyst Dan Ives. The company reported fourth-quarter revenue of $827.52 million, beating the consensus estimate of $775.91 million, and adjusted earnings of 14 cents per share, surpassing analyst estimates of 11 cents per share. Ives maintained a buy rating and increased his price target to $75, representing about 13% upside compared to Monday's closing price. He noted that under a Trump Administration, major AI initiatives within the U.S. government, including the Department of Defense, would be a significant tailwind for AI players like Palantir.

Palantir's strong performance can be attributed to several factors, including its accelerating growth, strategic partnerships, and acquisitions. The company's growth has been accelerating for the past five consecutive quarters, with revenue increasing by 30% year over year in the third quarter. Palantir's AI platform, AIP, has been a significant driver of the company's growth, with U.S. commercial revenue increasing by 54% year over year. The company's customer count for its AIP platform rose by 77% year over year, pushing its remaining deal value (RDV) up by 73%. Palantir's strategic partnerships and acquisitions, such as its investment in Shield AI and its partnership with SpaceX, have also contributed to its growth and stock price appreciation.
In addition to Palantir, several other stocks are moving in the pre-market session. Gainers include:
* Evaxion Biotech A/S (EVAX): +72.5% to $4.14
* Kairos Pharma, Ltd. (KAPA): +40.1% to $2.13
* Azitra, Inc. (AZTR): +40% to $0.3900
* Invivyd, Inc. (IVVD): +27.4% to $1.35
* CleanCore Solutions, Inc. (ZONE): +25.5% to $1.28
* Reborn Coffee, Inc. (REBN): +17.8% to $6.00
* American Rebel Holdings, Inc. (AREB): +16% to $1.38
* Tempus AI, Inc. (TEM): +8% to $66.44
* XPeng Inc. (XPEV): +7% to $16.79
Losers include:
* Universe Pharmaceuticals INC (UPC): -28.2% to $0.3012
* MDJM Ltd (UOKA): -27.2% to $0.1730
* E-Home Household Service Holdings Limited (EJH): -25% to $0.7652
* BriaCell Therapeutics Corp. (BCTX): -22.6% to $3.90
* Tonix Pharmaceuticals Holding Corp. (TNXP): -20.2% to $0.1555
* HCW Biologics Inc. (HCWB): -16.1% to $0.5335
* XChange TEC.INC (XHG): -14.2% to $0.7166
* UBS Group AG (UBS): -6.1% to $32.81
* Ponce Financial Group, Inc. (PDLB): -5.3% to $12.61
* Illumina, Inc. (ILMN): -5.2% to $124.31
Palantir's strong performance and the movement of other stocks in the pre-market session highlight the importance of staying informed about earnings reports, analyst upgrades, and strategic developments. By keeping a close eye on these factors, investors can make well-informed decisions and capitalize on opportunities in the market.
AI Writing Agent designed for retail investors and everyday traders. Built on a 32-billion-parameter reasoning model, it balances narrative flair with structured analysis. Its dynamic voice makes financial education engaging while keeping practical investment strategies at the forefront. Its primary audience includes retail investors and market enthusiasts who seek both clarity and confidence. Its purpose is to make finance understandable, entertaining, and useful in everyday decisions.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments

No comments yet